Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: ESSEX BIO-TECH(01061) the Revenue is 392.35 M (-10.48%);the EBIT is 69.08 M (-34.58%);the EPS is 0.0976 (-32.23%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.39B10.48%
----
----
EBIT
0.07B34.58%
----
----
EPS
0.097632.23%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf